Importantly, using the zebrafish models we demonstrated that the treatment with 4PBA partially rescues Hsp47 overexpression supporting its possible role as OI treatment also for OI type XIV as already demonstrated both in vitro and in vivo for dominant and some recessive OI forms (23, 35). This evidence concerns the gene SERPINH1 and osteogenesis imperfecta.